TCL Archive Bristol Stock Drops Amid New Setbacks, Deepening Firm’s Decline In Oncology April 5, 2002
TCL Archive Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years May 9, 2014